Pharmalyfe Limited in Glasgow, G73 1BZ

Description

Data updated on: 01-11-2023

The date the firm was founded is 2018-05-08. Registered under number SC596436, it is considered a Private Limited Company. You can contact the headquarters of this company during its opening times under the following address: 159 King Street Rutherglen, G73 1BZ Glasgow. This firm has a history in business name changes. In the past, it had two different company names. Before 2022 it was prospering as Enhance Pharma and up to that point the registered company name was Echo Pharma. The company's classified under the NACE and SIC code 74909, that means Other professional, scientific and technical activities not elsewhere classified. Pharmalyfe Ltd reported its account information for the period that ended on 2022/05/31. The company's latest annual confirmation statement was released on 2023/07/07.

For 6 years, this limited company has only had a single director: Ramzan J. who has been presiding over it since 2018-05-08.

Previous company's names
Pharmalyfe Limited 2022-09-05
Enhance Pharma Limited 2022-07-26
Echo Pharma Limited 2018-05-08

Financial data based on annual reports

Profit & Loss
Date of Accounts	2019-05-31	2020-05-31	2021-05-31	2022-05-31
Currency

Balance Sheet
Cash Bank On Hand	5 404	31 317	120 854	206 086
Current Assets	88 380	157 708	249 948	432 910
Debtors	5 476	13 891	13 594	21 324
Total Inventories	77 500	112 500	115 500	205 500

Other Financial Data
Accrued Liabilities	1 020	2 460	1 512	11 722
Average Number Employees During Period	2	1	3	3
Corporation Tax Payable	856	1 053	8 305	4 097
Creditors	84 731	153 304	210 221	375 716
Net Current Assets Liabilities	3 649	4 404	39 727	57 194
Number Shares Issued Fully Paid	1	1	1	1
Other Creditors	30 550
Par Value Share	1	1	1	1
Profit Loss	3 648	755	35 323	17 467
Recoverable Value-added Tax	5 476	13 891	13 594	21 324
Total Assets Less Current Liabilities	3 649	4 404	39 727	57 194
Bank Borrowings Overdrafts			50 000	43 532
Other Remaining Borrowings		21 000	21 000	15 167
Other Taxation Social Security Payable			257	141
Trade Creditors Trade Payables				175 566

Company staff

Ramzan J.

Role: Director

Appointed: 08 May 2018

Latest update: 17 December 2023

People with significant control

Ramzan J. is the individual who has control over this firm, has substantial control or influence over the company, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Ramzan J.

Notified on 8 May 2018

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

substantial control or influence

Accounts Documents

Account next due date	29 February 2024
Account last made up date	31 May 2022
Confirmation statement next due date	21 July 2024
Confirmation statement last made up date	07 July 2023

Annual Accounts
Start Date For Period Covered By Report	08 May 2018
End Date For Period Covered By Report	31 May 2019
Annual Accounts
Start Date For Period Covered By Report	01 June 2019
End Date For Period Covered By Report	31 May 2020
Annual Accounts
Start Date For Period Covered By Report	01 June 2020
End Date For Period Covered By Report	31 May 2021
Annual Accounts
Start Date For Period Covered By Report	01 June 2021
End Date For Period Covered By Report	31 May 2022
Annual Accounts
End Date For Period Covered By Report	31 May 2022

Pharmalyfe Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Ramzan J.

People with significant control

Ramzan J.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode